Population pharmacokinetic study in Dravet's syndrome patients treated with stiripentol, valproate and clobazam. Open pharmacokinetic multicenter study.

Trial Profile

Population pharmacokinetic study in Dravet's syndrome patients treated with stiripentol, valproate and clobazam. Open pharmacokinetic multicenter study.

Completed
Phase of Trial: Phase II

Latest Information Update: 17 Aug 2017

At a glance

  • Drugs Stiripentol (Primary) ; Clobazam; Valproic acid
  • Indications Myoclonic epilepsies
  • Focus Pharmacogenomic; Pharmacokinetics
  • Most Recent Events

    • 17 Aug 2017 Results published in the Clinical Pharmacokinetics
    • 17 Aug 2017 Status changed from recruiting to completed,as per results published in the Clinical Pharmacokinetics.
    • 21 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top